Encorafenib and Impurities
Ref: 4Z-E-183004
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-183017
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-183014
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-183008
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-183016
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-183012
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-183018
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-183011
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-183013
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-183009
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-183010
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-183015
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-183003
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-183002
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Encorafenib
CAS:1269440-17-6
Encorafenib (LGX818) is an orally available mutated BRaf V600E inhibitor(IC50=0.3 nM) with potential antineoplastic activity.
Formula:
C22H27ClFN7O4S
Purity:
98.64% - 99.74%
Color and Shape:
Solid
Molecular weight:
540.01
Ref: TM-T6487
1mg | 51.00 € | ||
5mg | 93.00 € | ||
10mg | 120.00 € | ||
25mg | 184.00 € | ||
50mg | 350.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-183001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-183005
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-183007
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-183006
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
N-nitroso Encorafenib
Controlled ProductFormula:
C22H26ClFN8O5S
Color and Shape:
Neat
Molecular weight:
569.01
Ref: TR-N769460
100mg | 1,060.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025